[Malignant pleural effusions. Pathophysiology, diagnosis and therapy].
Kreuser
E D
ED
D000042:Absorption; D000681:Amylases / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology; D001984:Bronchial Neoplasms / Q000473:pathology; D002199:Capillary Permeability; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002404:Catheterization; D004322:Drainage; D004417:Dyspnea / Q000175:diagnosis; D005337:Fibrin; D005374:Filtration; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008223:Lymphoma / Q000473:pathology; D010146:Pain / Q000175:diagnosis; D010190:Pancreatic Neoplasms / Q000175:diagnosis; D010996:Pleural Effusion / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D010997:Pleural Neoplasms / Q000473:pathology / Q000556:secondary; D011257:Pregnancy Proteins / Q000032:analysis; D011796:Quinacrine / Q000627:therapeutic use; D013627:Talc / Q000627:therapeutic use; D013754:Tetracyclines / Q000627:therapeutic use; D014014:Tissue Adhesives; D014463:Ultrasonography
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D011257:Pregnancy Proteins; D013754:Tetracyclines; D014014:Tissue Adhesives; D013627:Talc; D005337:Fibrin; D000681:Amylases; D011796:Quinacrine
Maligne Pleuraergüsse. Pathophysiologie, Diagnostik und Therapie.